American Research & Management Company’s Ambev ABEV Stock Holding History

American Research & Management Company’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2K	Buy	+783	New	+$2.22K	﹤0.01%	373

Other funds holding ABEV

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.68B AUM 76.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $625M AUM 21.08% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

American Research & Management Company's ABEV Position: Q3 2022 in Review

American Research & Management Company opened a new position in Ambev (ABEV) in Q3 2022: 783 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #373 among its holdings.

295 funds tracked by Wall St. Rank hold ABEV as of Q3 2022.

American Research & Management Company held 783 shares of Ambev worth $2K as of Q3 2022.
Ambev was a new American Research & Management Company position in Q3 2022.
Ambev made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #373 holding.
295 funds tracked by Wall St. Rank held Ambev as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.